Potential new treatment for sepsis

Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results.

The sepsis drug candidate, a carbohydrate-based drug called STC3141, was co-developed by Distinguished Professor…